Advertisement

Are agents affecting platelet functions clinically useful?

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Many studies have been performed recently on the usefulness of drugs affecting platelet functions in the prevention of arterial and venous thrombosis. This work is reviewed here and some clinical recommendations are made.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Havig O
        Pathogenesis of peripheral venous thrombosis. An autopsy study.
        in: Proceedings of the 4th International Congress on Thrombosis and Haemostasis, Vienna1973: 275
        • Emmons P.R.
        • Harrison M.J.G.
        • Honour A.J.
        • et al.
        Effect of dipyridamole on human platelet behavior.
        Lancet. 1965; 2: 603
        • Sullivan J.M.
        • Kagnoff M.F.
        • Gorlin R
        Reduction of platelet adhesiveness in patients with coronary artery disease.
        Am J Med Sci. 1968; 255: 292
        • Bouvier C.A.
        • Rosner P
        • Berthoud S
        • et al.
        Anomalies du comportement plaquettaire lors d'infarctus du myocarde.
        Cardiologia. 1967; 50: 232
        • Gray G.R.
        • Wilson P.A.
        • Douglas A.S.
        The effect of dipyridamole on platelet aggregation and adhesiveness.
        Scott Med J. 1968; 13: 409
        • Harker L.A.
        • Slichter S.J.
        Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
        N Engl J Med. 1970; 283: 1302
        • Harker L.A.
        • Slichter S.J.
        Platelet and fibrinogen consumption in man.
        N Engl J Med. 1972; 287: 999
        • Harker L.A.
        • Slichter S.J.
        • Scott C.R.
        • et al.
        Homocystinemia. Vascular injury and arterial thrombosis.
        N Engl J Med. 1974; 291: 537
        • Harker L.A.
        In vivo evaluation of antithrombotic therapy in man.
        in: Didisheim P Shimamoto T Yamazaki H Platelets, Thrombosis and Inhibitors. F. K. Schattauer Verlag, Stuttgart-New-York1974: 481
        • O'Brien J.R.
        Effect of salicylates on human platelets.
        Lancet. 1968; 1: 779
        • Zucker M.B.
        • Peterson J
        Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion.
        in: Proc Soc Exp Biol Med. 127. 1968: 547
        • Stuart R.K.J.
        Platelet function studies in human beings receiving 300 mg of aspirin per day.
        J Lab Clin Med. 1970; 75: 463
        • Smythe H.A.
        • Ogryzlo M.A.
        • Murphy E.A.
        • et al.
        The effect of sulfinpyrazone (Anturan) in platelet economy and blood coagulation in man.
        Can Med Assoc J. 1965; 92: 818
        • Weily H.S.
        • Genton E
        Altered platelet function in patients with prosthetic mitral valves effects of sulfinpyrazone therapy.
        Circulation. 1970; 42: 967
        • Gilbert J.B.
        • Mustard J.F.
        Some effects of Atromid on platelet economy and blood coagulation in man.
        J Atheroscler Res. 1963; 3: 623
        • Carson P
        • MacDonald L
        • Pickard S
        • et al.
        Effect of Atromid on platelet stickiness.
        J Atheroscl Res. 1963; 3: 619
        • Cronberg S
        • Robertson B
        • Nilsson I.M.
        • et al.
        Suppressive effect of dextran on platelet adhesiveness.
        Thromb Diath Haemorrh. 1966; 16: 384
        • Perkins H.A.
        • Rolfs M.R.
        • McBride A
        Low molecular weight dextran in open heart surgery: effect on coagulation factors and on red cell antibody activity.
        Transfusion. 1964; 4: 10
        • Muzaffar T.Z.
        • Stalker A.L.
        • Bryce W.A.J.
        • et al.
        Dextran and fibrin morphology.
        Nature (Lond). 1972; 238: 288
        • Metcalf M.J.
        • Arfors K.E.
        • McKenzie F.N.
        • et al.
        Effect of dextran on the lysis of artificial thrombi.
        Europ Surg Res. 1974; 6: 28
        • Hynes K.M.
        • Gau G.T.
        • Rutherford B.D.
        • et al.
        Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography.
        Circulation. 1973; 47: 554
        • Freed M.D.
        • Rosenthal A
        • Fyler D
        Attempts to reduce arterial thrombosis after cardiac catheterization in children: use of percutaneous technique and aspirin.
        Am Heart J. 1974; 87: 283
        • Linke H
        Langzeitprophylaxe mit ASS (Colfarit) bei arteriellen Angiopathien.
        Therapeutische Berichte. 1975; 47: 33
        • Kurtzke J.P.
        • Kurland L.T.
        Epidemiology of cerebrovascular disease.
        in: Cerebrovascular Survey Report. Subcommittee on Cerebrovascular Disease NINDS, Washington DC1970: 163
        • Barnett H.J.M.
        Platelets, drugs and cerebral ischemia.
        in: Hirsch J Cade J.F. Gallus A.S. Schönbaum E Platelets, Drugs and Thrombosis. S. Karger, Basel1975: 233
        • Baker R.N.
        • Broward J.A.
        • Fant H.C.
        • et al.
        Anticoagulant therapy in cerebral infarction.
        Neurology (Minneap). 1962; 12: 823
        • Friedman G.D.
        • Wilson S
        • Mosier J.M.
        • et al.
        Transient ischemia attacks in a community.
        JAMA. 1969; 210: 1428
        • Acheson J
        • Danta G
        • Hutchinson E.C.
        Controlled trial of dipyridamole in cerebral vascular disease.
        Br Med J. 1969; 1: 614
        • Acheson J
        • Hutchinson E.C.
        Controlled trial of clofibrate in cerebral vascular disease.
        Atherosclerosis. 1972; 15: 177
        • Evans G
        • Gent M
        Effect of platelet suppressive drugs on arterial and venous thromboembolism.
        in: Hirsch J Cade J.F. Gallus A.S. Schönbaum E Platelets, Drugs and Thrombosis. S. Karger, Basel1975: 258
        • Blakely J.A.
        • Gent M
        Platelets, drugs and longevity in a geriatric population.
        in: Hirsh J Cade J.F. Gallus A.S. Schönbaum E Platelets, Drugs and Thrombosis. S. Karger, Basel1975: 284
        • Heikinheimo R
        • Jarvinen K
        Acetylsalicylic acid and arteriosclerotic-thromboembolic diseases in the aged.
        J Am Geriat Soc. 1971; 19: 403
        • Dyken M.L.
        • Kolar O.J.
        • Jones F.H.
        Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy.
        Stroke. 1973; 4: 732
        • Harrison M.J.G.
        • Marshall J
        • Meadows J.C.
        • et al.
        Effect of aspirin in amaurosis fugax.
        Lancet. 1971; 2: 743
        • Mundall J
        • Quintero P
        • Von Kaulla K.N.
        • et al.
        Transient monocular blindness and increased platelet aggregability treated with aspirin—a case report.
        Neurology (Minneap). 1971; 21: 402
        • Gent M
        • Barnett H.J.M.
        The Canadian Cooperative study of recent recurrent presumed cerebral emboli (RRPCE).
        in: A progress report (Abstract), IVth Congress of the International Society of Thrombosis and Haemostasis, Vienna, Austria1973: 165
        • Boneu B
        • Guiraud B
        • Fernet P
        Traitement anti-agrégant plaquettaire par l,aspirine. Bases biologiques. Application, aux accidents vasculaire cérébraux.
        Nouv Presse Méd. 1972; 1: 863
        • Newcastle upon Tyne Physicians
        Trial of clofibrate in the treatment of ischemic heart disease.
        Br Med J. 1971; 4: 1767
        • Scottish Society of Physicians
        Ischemic heart disease: a secondary prevention trial using clofibrate.
        Br Med J. 1971; 2: 775
        • Gilbert J.B.
        • Mustard J.F.
        Some effects of Atromid on platelet economy and blood coagulation in man.
        J Atheroscler Res. 1963; 3: 623
        • Coronary drug project research group
        clofibrate and niacin in coronary heart disease.
        JAMA. 1975; 27: 360
        • Gent A.E.
        • Brook C.G.D.
        • Foley T.H.
        • et al.
        Dipyridamole: a controlled trial of its effect in acute myocardial infarction.
        Br Med J. 1968; 4: 366
        • Foulds T
        • Mackinnon J
        Controlled double-blind trial of “Persantin” in treatment of angina pectoris.
        Br Med J. 1960; 2: 835
        • Zion M.M.
        • Bradlow B.A.
        A controlled clinical trial of “Persantin” (RA8) in angina pectoris.
        S Afr Med J. 1961; 35: 11
        • Soloff L.A.
        • Gimenez J.L.
        • Winters Jr, W.L.
        Experimental and clinical observations on 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,5-d) pyrimidine (Persantin).
        Am J Med Sci. 1962; 243: 783
        • Sbar S
        • Schlant R.C.
        Dipyridamole in the treatment of angina pectoris: a double-blind evaluation.
        JAMA. 1967; 201: 865
        • Cobb S
        • Anderson F
        • Bauer W
        Length of life and causes of death in rheumatoid arthritis.
        N Engl J Med. 1953; 249: 553
        • Boston Collaborative Drug Surveillance Group
        Regular aspirin intake and acute myocardial infarction.
        Br Med J. 1974; 1: 440
        • Hammond E.C.
        • Sarfinkel L
        Aspirin and coronary heart disease: findings of a prospective study.
        Br Med J. 1975; 1: 269
        • Craven L.L.
        Experiences with aspirin (acetylsalicylic acid) in nonspecific prophylaxis of coronary thrombosis.
        Mississipi Valley Med J. 1953; 75: 38
        • Elwood P.C.
        • Cochrane A.L.
        • Burr M.L.
        • et al.
        A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.
        Br Med J. 1974; 1: 436
        • Weily H.S.
        • Steele P.P.
        • Genton E
        Platelet survival in patients with a Beall valve. Relation to low incidence of thromboembolism.
        Am J Cardiol. 1972; 30: 229
        • Warkany J
        Warfarin embryopathy.
        Am J Dis Childr. 1975; 129: 287
        • Sullivan J.M.
        • Harken D.E.
        • Gorlin R
        Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
        N Engl J Med. 1968; 279: 576
        • Sullivan J.M.
        • Harken D.E.
        • Gorlin R
        Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
        N Engl J Med. 1971; 284: 1391
        • Arrants J.E.
        • Hairston P
        • Lee Jr, W.H.
        Use of dipyridamole (persantine) in preventing thromboembolism following valve replacement.
        Chest. 1970; 58: 275
        • Rabello C
        • Rivas J.A.
        • Rocha F
        • et al.
        Estudo da açā de Dipiridamol na evoluçāo de pacientes submetiødos á substituiçao de próteses valvares.
        Rev Bras clin ter. 1973; 2: 95
        • Lander H
        • Kinlough R.L.
        • Robson H.N.
        reduced platelet survival in patients with Starr-Edwards prostheses.
        Br Med J. 1965; 1: 688
        • Manohitharajah S.M.
        • Rahman A.N.
        • Donnely R.J.
        • et al.
        Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.
        Thorax. 1974; 29: 639
        • Weily H.S.
        • Steele P.P.
        • Davies H
        • et al.
        Platelet studies in patients with substitute heart valves.
        N Engl J Med. 1974; 290: 534
        • Steele P.P.
        • Davies H
        • Genton E
        Platelet function studies in coronary artery disease.
        Circulation. 1973; 48: 1194
        • Kummer H
        • Hunziker H.R.
        • Althaus U
        Medicamentöse Beeinflussüng des Thrombocytenumsatzes bei Patienten mit künstlichen Herzklappen.
        Schweiz Med Wochenschr. 1974; 104: 142
        • Stuart R.K.
        • McDonald J.W.D.
        • Ahujy S.P.
        • et al.
        Platelet survival in prosthetic heart valve patients (abstract).
        in: IIIrd Congress of the International Society of Thrombosis and Haemostasis, Washington DC1972: 384
        • Genton E
        • Steele P
        Platelets, drugs and heart disease.
        in: Hirsh J Cade J.F. Gallus A.S. Schönbaum E Platelets, Drugs and Thrombosis. S. Karger, Basel1975: 263
        • Garg S.K.
        • Lackner H
        • Karpatkin S
        The increased percentage of megacaryocytes in various clinical disorders.
        Ann Intern Med. 1972; 77: 361
        • Farquhar M.G.
        • Vernier R.L.
        • Good R.A.
        Electron microscopy of the glomerulus in nephrosis, glomerulohephritis and lupus erythematosus.
        J Exp Med. 1957; 106: 649
        • Koffler D
        • Paronetto F
        Immunofluorescent localization of immuneglobulins, complement and fibrinogen in human disease. II. Acute, subacute, and chronic glomerulonephritis.
        J Clin Invest. 1965; 44: 1665
        • Duffy J.L.
        • Cinque T
        • Grisham E
        • et al.
        Intraglomerular fibrin platelet aggregation and subendothelial deposits in lipoid nephritis.
        J Clin Invest. 1970; 49: 251
        • Fischel E.E.
        Immune reactions in human glomerulonephritis.
        J Chronic Dis. 1957; 5: 34
        • Friedman P
        • Markowitz A.A.
        Gamma globulin and complement in diseased kidney.
        J Clin Invest. 1962; 41: 328
        • Kincaid-Smith P
        • Saker B.M.
        • Fairly K.F.
        Anticoagulants in “irreversible” acute renal failure.
        Lancet. 1968; 2: 1360
        • Herdman R.C.
        • Edson J.R.
        • Pickering R.J.
        • et al.
        Anticoagulation in renal diseases in children.
        Am J Dis Child. 1970; 119: 27
        • Cade J.R.
        • De Quesada A.M.
        • Shires D.L.
        • et al.
        The effect of long term high dose heparin treatment on the course of chronic proliferative glomerulonephritis.
        Nephron. 1971; 8: 67
        • Kincaid-Smith P
        Coagulation and renal disease.
        Kidney Int. 1972; 2: 183
        • Bello E
        • Reuss L
        • Lazcano F
        • et al.
        Tratamiento de glomerulopatias proliferativas y mesengioproliferativas con heparina-deipiridamol.
        Rev Méd Chile. 1973; 101: 279
        • Trygstad C.W.
        • Bang N.U.
        • Heidenreich R.O.
        • et al.
        A controlled trial of aspirin in childhood glomerular disorders.
        Thromb Diath Haemorrh. 1973; 30: 12
        • Kincaid-Smith P
        Platelets, drugs and the kidney.
        in: Hirsh J Cade J.F. Gallus A.S. Schönbaum E Platelets, Drugs and Thrombosis. S. Karger, Basel1975: 301
        • Porter K.A.
        • Calne R.Y.
        • Zukoski C.F.
        Vascular and other changes in 200 canine renal homotransplants treated with immunosuppressive drugs.
        Lab Invest. 1964; 13: 810
        • Kissmeyer-Neilsen F
        • Olsen S
        • Petersen V.P.
        • et al.
        Hyperacute rejection of kidney allografts associated with preexisting humoral antibodies against donor cells.
        Lancet. 1966; 2: 662
        • Mowbray J.F.
        Methods of suppression of immune response.
        in: Proceedings of the 9th International Congress on Internal Medicine. vol 137. Excerpta Medica, Amsterdam1966: 106
        • Lowenhaupt R.W.
        • Nathan P
        Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection.
        Nature (Lond). 1968; 220: 822
        • Busch G.J.
        • Braun W.E.
        • Carpenter C.B.
        • et al.
        Intravascular coagulation (IVC) in human renal allograft rejection.
        Transplantation. 1969; 1: 267
        • Kincaid-Smith P
        • McKenzie I.F.C.
        • Morris P.J.
        • et al.
        Biopsy features of early acute rejection in cadaveric renal grafts.
        Transplantation. 1969; 1: 287
        • Simpson K.M.
        • Bunc D.L.
        • Amemiya H
        • et al.
        Humerol antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.
        Surgery. 1970; 68: 77
        • Kincaid-Smith P
        The pathogenesis of the vascular and glomerular lesions of rejection in renal allografts and their modification by antithrombotic and anticoagulant drugs.
        Aust Ann Med. 1970; 3: 201
        • McMillan R
        Heparin in delayed transplant function.
        Lancet. 1968; 1: 1178
        • Macdonald A
        • Busch G.J.
        • Alexander J.L.
        • et al.
        Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs.
        Transplantation. 1970; 9: 1
        • Mathew T.H.
        • Hogan G.P.
        • Lewers D.T.
        • et al.
        Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
        Transplant Proc. 1971; 3: 901
        • Sharma H.M.
        • Moore S
        • Merrick H.W.
        • et al.
        Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy.
        Am J Pathol. 1972; 66: 445
        • Messmer K
        • Hammer C
        • Land W
        • et al.
        Modification of hyperacute xenogeneic kidney rejection.
        Transplant Proc. 1971; 3: 542
        • Claes G
        Studies on platelets and fibrin during rejection of canine allografts.
        Scand J Urol Nephrol (suppl). 1972; 10: 1
        • Shons A.R.
        • Navajarian J.S.
        Modification of xenograft rejection by aspirin, dextran, and cinanserin: the importance of platelets in hyperacute rejection.
        Transplant Proc. 1974; 6: 435
        • Australian National Renal Transplantation Survey
        Second report by a subcommittee.
        Med J Aust. 1971; 2: 605
        • Advisory Committee to the Renal Transplant Registry
        The ninth report of the human renal transplantation registry.
        JAMA. 1972; 220: 253
        • Lowrie E.G.
        • Lazarus J.H.
        • Mocellin A.J.
        • et al.
        Survival of patients undergoing chronic hemodialysis and renal transplantation.
        N Engl J Med. 1973; 288: 863
        • Ibels L.S.
        • Stewart J.H.
        • Mahony J.F.
        • et al.
        Deaths from occlusive arterial disease in renal allograft recipients.
        Br Med J. 1974; 2: 552
        • Kincaid-Smith P
        Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.
        Lancet. 1969; 2: 920
        • Aledort L.M.
        • Taub R
        • Burrows L
        • et al.
        Use of inhibitors of platelet function in renal rejection phenomena.
        in: Sherry S Scriabine A Platelets and Thrombosis. Urban and Schwarzenberg, München1974: 263
        • Mathew T.H.
        • Clyne D.H.
        • Nanra R.S.
        • et al.
        A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts.
        Lancet. 1974; 1: 1307
        • Griepp R.B.
        • Stinson E.B.
        • Dong E
        • et al.
        The influence of warfarin and dipyridamol on coronary arteriosclerosis in the transplanted human heart.
        Circulation. 1973; 7–8: 98
        • Giromini M
        • Bouvier C.A.
        • Dami R
        • et al.
        Effect of dipyridamole and aspirin in thrombotic microangiopathy.
        Br Med J. 1972; 1: 545
        • Utting J.A.
        • Shreeve D.R.
        Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy.
        Br Med J. 1973; 2: 591
        • Amir J
        • Krauss S
        Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.
        Blood. 1973; 42: 27
        • Rossi E.C.
        • Redondo D
        • Borges W.H.
        Thrombotic thrombocytopenic purpura survival following treatment with aspirin, dipyridamole and prednisone.
        JAMA. 1974; 228: 1141
        • Powell H.R.
        • Ekert H
        Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome.
        J Pediatr. 1974; 84: 345
        • Howard D.J.
        • Roberts A.B.
        • Page F.T.
        Late recurrence of thrombotic thrombocytopenic purpura after splenectomy.
        Br Med J. 1975; 1: 317
        • O'Brien J.R.
        Effects of salicylates in human platelets.
        Lancet. 1968; 1: 779
        • Clagett G.P.
        • Schneider P
        • Rosoff C.B.
        • et al.
        The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
        Surgery. 1975; 77: 61
        • Browse N.L.
        • Hall J.H.
        Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis.
        Lancet. 1969; 2: 718
        • Weber W
        • Wolff U
        • Bromig G
        Postoperative Thromboembolieprophylaxe mit Colfarit.
        Ther Berichte (Bayer, Leverkusen). 1971; 43: 229
        • Salzman E.W.
        • Harris W.H.
        • DeSanctis R.W.
        Reduction in venous thromboembolism by agents affecting platelet function.
        N Engl J Med. 1971; 284: 1287
        • Harris W.H
        • Salzman E.W.
        • DeSanctis R.W.
        • et al.
        Prevention of venous thromboembolism following total hip replacement.
        JAMA. 1972; 220: 1319
        • Zekert F
        • Kohn P
        • Vormittag E
        • et al.
        Thromboembolieprophylaxe mit Acetylsalicylsäure bei Operationen wegen hüftgelenksnaher Frakturen.
        Mschr Unfallheilk. 1974; 77: 97
        • Loew D
        • Wellmer H.K.
        • Baer U
        • et al.
        Postoperative Thromboembolie-Prophylaxe mit Acetylsalicylsäure.
        Dtsch Med Wochenschr. 1974; 99: 565
        • Carter A.E.
        • Eban R
        • Perrett R.D.
        Prevention of postoperative deep vein thrombosis and pulmonary embolism.
        Br Med J. 1971; 1: 312
        • O'Brien J.R.
        • Tulevski V.G.
        • Etherington M
        Two in-vivo studies comparing high and low aspirin dosage.
        Lancet. 1971; 2: 388
        • British Medical Research Council
        Effect of aspirin on postoperative venous thrombosis.
        Lancet. 1972; 2: 441
        • O'Sullivan E.F.
        • Vellar I.D.A.
        Assessment of the efficacy of antiplatelet drugs in the prevention of postoperative deep vein thrombosis.
        in: IIIrd Congress International Society of Thrombosis and Haemostasis, Washington DC1972: 438
        • Parodi J.C.
        • Grandi A
        • Font E
        • et al.
        El dipyridamol y el acido acetilsalicilico en la profilaxis de las thrombosis venosas postoperatorias de los membres inferiores.
        Dia méd. 1973; 44: 92
        • Wood E.H.
        • Prentice C.R.M.
        • McGrouther D.A.
        • et al.
        Trial of aspirin and RA-233 in prevention of post-operative deep vein thrombosis.
        Thromb Diath Haemorrh. 1973; 30: 18
        • Harris W.H.
        • Salzman E.W.
        • Athanasoulis C
        • et al.
        Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
        J Bone Joint Surg. 1974; 56: 1552
        • Carter A.E.
        • Eban R
        Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate.
        Br Med J. 1974; 2: 94
      1. Weiss V, Jekiel M, Bouvier CA: Preventive effects of dipyridamole and ASA on postoperative thrombo-embolic disease in gynaecological surgery. J Int Fed Obst Gynecol, to be published.

        • Kline A
        • Hughes L.E.
        • Campbell H
        • et al.
        Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.
        Br Med J. 1975; 2: 109
        • Kakkar V.V.
        Review of present status of prophylaxis of venous thromboembolism.
        in: Proc Roy Soc Med. 67. 1974: 706
        • Jansen H
        Postoperative thromboembolism and its prevention with 500 ml dextran given during operation.
        Acta Chir Scand suppl. 1972; 427: 86
        • Carter A.E.
        • Eban R
        The prevention of postoperative deep venous thrombosis with dextran 70.
        Br J Surg. 1973; 60: 681
        • Stephenson C.B.S.
        • Wallace J.C.
        • Vaughan J.V.
        Dextran 70 in the prevention of post-operative deep vein thrombosis with observations on pulmonary embolism: report on a pilot study.
        NZ Med J. 1973; 77: 302
        • Becker J
        • Schampi B
        The incidence of postoperative venous thrombosis of the legs.
        Acta Chir Scand. 1972; 139: 357
        • Ruckley C.V.
        Heparin versus dextran in the prevention of deep-vein thrombosis.
        Lancet. 1974; 2: 118
        • Gruber U.F.
        • Sturm V
        • Rem J
        • et al.
        The present state of prevention of postoperative thromboembolic complications.
        in: Intentional Hemodilution. Bibl Haematol. 41. 1975: 98
        • Lambie J.M.
        • Barber D.C.
        • Dhall D.P.
        • et al.
        Dextran 70 in prophylaxis of postoperative venous thrombosis' A controlled trial.
        Br Med J. 1970; 2: 144
        • Davidson A.I.
        • Brunt M.E.A.
        • Matheson N.A.
        A further trial comparing Dextran 70 with Warfarin in the prophylaxis of postoperative venous thrombosis.
        Br J Surg. 1972; 59: 314
        • Bonnar J
        • Walsh J
        Prevention of thrombosis after pelvic surgery by British Dextran 70.
        Lancet. 1972; 1: 614
        • Bonnar J
        • Walsh J.J.
        • Haddon M
        • et al.
        Coagulation system changes induced by pelvic surgery and the effect of Dextran 70.
        Bibl Anat. 1973; 12: 351
        • McCarthy T.G.
        • McQueen J
        • Johnstone F.D.
        • et al.
        A comparison of low-dose subcutaneous heparin and intravenous dextran 70 in the prophylaxis of deep venous thrombosis after gynecological surgery.
        J Obstet Gynaecol Br. 1974; 81: 486
        • Hedlund P.O.
        Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients with the 125Ifibrogen uptake test.
        Scand J Urol Nephrol suppl. 1975; 27: 1
        • Johnsson S.R.
        • Bygdeman S
        • Eliasson R
        Effect of dextran on postoperative thrombosis.
        Acta Chir Scand suppl. 1968; 387: 80
        • Ahlberg A
        • Göran N
        • Robertson B
        • et al.
        Dextran in prophylaxis of thrombosis in fractures in the hip.
        Acta Chir Scand suppl. 1968; 387: 83
        • Ahlberg A
        Haeger K Robertson B Thromboprofylaxe med Macrodex i ett collumfrakturmaterial, Symposium. Studentlitteratur, Lund1969: 89
        • Myhre H.O.
        • Holen A
        Thromboseprofylakse. Dextran eller Warfarin-natrium? et kontrolleert klinisk forsok.
        Nord Med. 1969; 82: 1534
        • Evarts C.M.
        • Feil E.I.
        Prevention of thromboembolic disease after elective surgery of the hip.
        J Bone Joint Surg. 1971; 53: 1271
        • Bronge A
        • Dahlgren S
        • Lindquist B
        Prophylaxis against thrombosis in femoral neck fracture—a comparison between dextran 70 and dicumarol.
        Acta Chir Scand. 1971; 137: 29
        • Daniel W.J.
        • Moore A.R.
        • Flanc C
        Prophylaxis of deep vein thrombosis (DM) with dextran 70 in patients with a fractured neck of femur.
        Austr NZ J Surg. 1972; 41: 289
        • Bergquist E
        • Bergquist D
        • Bronge A
        • et al.
        An evaluation of early thrombosis prophylaxis following fracture of the femoral neck.
        Acta Chir Scand. 1972; 138: 689
        • Myrvold H.E.
        • Persson J.E.
        • Svensson B
        • et al.
        Prevention of thromboembolism with dextran 70 and heparin in patients with femoral neck fractures.
        Acta Chir Scand. 1973; 139: 609
        • Korvald E
        • Støren E.J.
        • Ongre A
        Simultaneous use of warfarin—sodium and dextran 70 to prevent postoperative venous thrombosis in patients with hip fractures.
        J Oslo City Hosp. 1973; 23: 25
        • Bergqvist D
        • Dahlgren S
        Leg vein thrombosis diagnosed by 125I-fibrinogen test in patients with fracture of the hip: a study of the effect of early prophylaxis with dicoumarol or dextran 7.
        VASA. 1973; 2: 121
        • Harper D.R.
        • Dhall D.P.
        • Woodruff P.W.T.T.
        Prophylaxis in iliofemoral venous thrombosis. The major amputee as a clinical research model.
        Br J Surg. 1973; 60: 831
        • Mavor G.E.
        • Golloway J.M.D.
        Iliofemoral venous thrombosis. Pathological considerations and surgical management.
        Br J Surg. 1969; 56: 45
        • Sevitt S
        • Gallagher N
        Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenlndione in middle-aged and elderly patients with fractured necks of femur.
        Lancet. 1959; 2: 981
        • Kakkar V.V.
        • Field E.S.
        • Nicolaides A.N.
        • et al.
        Low dose of heparin in the prevention of deep vein thrombosis.
        Lancet. 1971; 2: 699
        • An International Multicentre Trial
        Prevention of fatal postoperative pulmonary embolism by low doses of heparin.
        Lancet. 1975; 2: 45
        • Steele P.P.
        • Weily H.S.
        • Genton E
        Platelet survival and adhesiveness in recurrent venous thrombosis.
        N Engl J Med. 1973; 288: 1148
        • Abrahamsen A.F.
        Platelet survival studies in man: with special reference to thrombosis and atherosclerosis.
        Scand J Haematol suppl. 1968; 3: 1
        • Smythe H.A.
        • Ogryzlo M.A.
        • Murphy E.A.
        • et al.
        The effect of sulphinpyrazone (Anturan) in platelet economy and blood coagulation in man.
        Can Med Assoc J. 1965; 92: 818
        • Tautz I
        Die Behandlung der oberflachigen Thrombophlebitis mi colfarit.
        Therapiewoche. 1972; 22: 1407
        • Sellier W
        Erfahrungen mit dem Thrombozytenaggregationshemmer Colfarit bei thromboembolischen Erkrankungen in der Praxis.
        Med Welt. 1971; 22: 2013
        • Knappmann J
        Erfahrungen mit dem Acetylsalicyl-Säurepräparat “Colfarit.” Beobachtungen an 112 Patienten.
        Med Welt. 1971; 48: 1929
        • Joist J.H.
        Medikamentöse Hemmung der Blutplättchenfunktion.
        Med Welt. 1970; 27: 1247
        • Scharrer I
        • Schepping M
        • Breddin K
        Thromboseprophylaxe mit Aspirin der Einfluss von Acetylsalicylsaüre auf die Thrombocytenaggregaten in vitro and in vivo.
        Klin Wochenschr. 1969; 24: 1318
        • Hach W
        Thromboseprophylaxe nach Phlebographie.
        in: Proceedings of the Colfarit symposium II, Bayer Pharma, 1973 Pharma-Forschungszentrum, Wuppertal; BayerSeptember 28, 1973: 53
        • Mustard J.F.
        • Rowsell H.C.
        • Smythe H.A.
        • et al.
        The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
        Blood. 1967; 29: 859
        • Didisheim P
        Inhibition by dipyridamole of arterial thrombosis in rats.
        Thromb Diath Haemorrh. 1968; 20: 257
        • Benis A.M.
        • Nossel H.L.
        • Aledorf L.M.
        • et al.
        Thrombus formation in flow chambers studied with dogs having long-term extracorporeal shunts.
        in: Abstracts, IIIrd Congress International Society of Thrombosis and Haemostasis, Washington DC1972: 352
        • Scribner B.H.
        • Thomas G.I.
        • Slichter S.J.
        • et al.
        Studies of platelet destruction due to prosthetic arterio-venous cannulas.
        in: Fourth Annual Contractors Conference of the Artificial Kidney Program of the National Institute of Arthritis and Metabolic Diseases, Washington DC1971
        • Koestering H
        • Mietzsch G
        • Wigger W
        • et al.
        Thrombolyse zur Beseitigung thrombotischer Verschlüsse beim cimino-shunt bei Hämodialysepatienten.
        Med Klin. 1972; 67: 945
        • Lindsay R.M.
        • Ferguson D
        • Prentice C.R.
        • et al.
        Reduction of thrombus formation on dialyser membranes by aspirin and RA-233.
        Lancet. 1972; 2: 1287
        • Kaegi A
        • Pineo G.F.
        • Shimizu A
        • et al.
        Arterio-venous shunt thrombosis. Prevention by sulfinpyrazone.
        N Engl J Med. 1974; 290: 304
        • Hirsh J
        • Gent M
        • Genton E
        The current status of platelet suppressive drugs in the treatment of thrombosis.
        Thromb Diath Haemorrh. 1973; 33: 406
        • Andrassy K
        • Ritz E
        • Schoeffner W
        • et al.
        The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients.
        Klin Wochenschr. 1971; 3: 166
        • Stuart M
        • Stockman J
        • Murphy S
        • et al.
        Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction.
        J Pediatr. 1972; 80: 21
        • Friedman S
        • Zita-Gozum C
        • Chatten J
        Pulmonary vascular changes complicating ventriculovascular shunting for hydrocephalus.
        J Pediatr. 1964; 64: 305